Table 1.
Comparison of clinical characteristics in the CHF and control group
| CHF group (n = 115) | Control group (n = 31) | P | |
|---|---|---|---|
| Age (y) | 70.75 (68.54-72.96) | 67.52 (63.70-71.35) | 0.08 |
| Gender (M/F) | 81/34 | 20/11 | 0.528 |
| Fasting blood glucose (mmol/L) | 5.4 (4.6-7.0) | 5.9 (5.03-6.60) | 0.724 |
| Haemoglobin (g/L) | 123 ± 22 | 126 ± 19 | 0.607 |
| D-dimer (μg/L) | 1.08 (0.733-1.540) | 1.18 (1.69-2.73) | 0.769 |
| TSH (mIU/L) | 1.920 (1.105-2.415) | 2.09 (1.69-2.73) | 0.321 |
| LDL-C (mg/dL) | 2.311 ± 0.891 | 2.266 ± 0.93 | 0.865 |
| HDL-C (mg/dL) | 0.990 (0.790-1.230) | 1.135 (0.970-1.330) | 0.103 |
| Ccr | 0.64 (0.44-0.86) | 0.97 (0.65-1.13) | 0.011 |
| BNP (pg/mL) | 737 (357-1498) | 80 (30-200) | 0.000 |
| LVEF (%) | 41 (35-51) | 64 (56-71) | 0.000 |
P < 0.05 was considered statistically significant. Normally distributed data are expressed as mean ± standard deviation. Non-normally distributed data are expressed as median (interquartile range). TSH, thyroid-stimulating hormone; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; Ccr, creatinine clearance rate; BNP, brain natriuretic peptide; LVEF, left ventricular ejection fraction.